An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...

Liver cancer often remains undetected until advanced stages. Learn about the causes and how you can protect yourself with ...

In summary, adopting an active lifestyle to prevent obesity and related metabolic disorders, getting vaccinated for HBV, ...

Throughout the 45-minute procedure of vascular embolization, a 70-year-old man sang 10 songs to “drown out the pain”, dedicating them to his doctors.

Discover the distinctive symptoms of liver pain, common underlying conditions, and effective treatment options to protect ...

Transplantation combined with immunotherapy to cure liver cancer. Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherap ...

A recent study unveils how stromal interaction molecule 1 (STIM1), a protein involved in calcium signaling, plays a pivotal ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...

Liver cancer is the fourth most common cancer and the fourth leading cause of cancer-related deaths in the country.